Risk factors for hepatotoxicity in patients hospitalized for tuberculosis


ERGAN B., Kirmizigul E., UZUN Ö. , ÇÖPLÜ L.

EUROPEAN JOURNAL OF GENERAL MEDICINE, cilt.14, ss.1-4, 2017 (ESCI İndekslerine Giren Dergi) identifier identifier

  • Cilt numarası: 14 Konu: 1
  • Basım Tarihi: 2017
  • Doi Numarası: 10.29333/ejgm/81870
  • Dergi Adı: EUROPEAN JOURNAL OF GENERAL MEDICINE
  • Sayfa Sayıları: ss.1-4

Özet

Introduction: Combination therapy with four drugs (isoniazid, rifampicin, pyrazinamid and ethambutol) is the treatment of choice in tuberculosis but hepatotoxicity due to these drugs is an important medical concern. Therefore identification of patient groups with increased risk for antituberculosis therapy induced hepatotoxicity is crucial.